Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear transcription factor Y subunit gamma is one component of a highly conserved heterotrimeric transcription factor (NF-Y) that specifically binds CCAAT motifs in the promoters of target genes. This subunit (gamma, or C) forms a dimer with the beta subunit (NFYB), allowing association with the alpha subunit (NFYA). NF-Y functions in both activation and repression of gene transcription, depending on its cofactors. The B and C subunits share histone-like motifs, supporting a structural and functional analogy to histone proteins. NFYC is encoded on human chromosome 1 and also hosts intronic microRNAs (miR-30c/e) involved in pancreatic islet cell differentiation and phenotype maintenance[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear transcription factor Y subunit gamma (NFYC).